0000707549-25-000016.txt : 20250206 0000707549-25-000016.hdr.sgml : 20250206 20250206160613 ACCESSION NUMBER: 0000707549-25-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250205 FILED AS OF DATE: 20250206 DATE AS OF CHANGE: 20250206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ARCHER TIMOTHY CENTRAL INDEX KEY: 0001343600 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12933 FILM NUMBER: 25597372 MAIL ADDRESS: STREET 1: 4650 CUSHING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LAM RESEARCH CORP CENTRAL INDEX KEY: 0000707549 STANDARD INDUSTRIAL CLASSIFICATION: SPECIAL INDUSTRY MACHINERY, NEC [3559] ORGANIZATION NAME: 06 Technology IRS NUMBER: 942634797 STATE OF INCORPORATION: DE FISCAL YEAR END: 0629 BUSINESS ADDRESS: STREET 1: 4650 CUSHING BLVD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 5106590200 MAIL ADDRESS: STREET 1: 4650 CUSHING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 4 1 wk-form4_1738875964.xml FORM 4 X0508 4 2025-02-05 0 0000707549 LAM RESEARCH CORP LRCX 0001343600 ARCHER TIMOTHY 4650 CUSHING PARKWAY FREMONT CA 94538 0 1 0 0 President and CEO 0 Common Stock 2025-02-05 4 M 0 86548 0 A 932940 D Common Stock 48026.049 I By 401(k) Common Stock 5670.281 I By Spouse 401(k) Market-based Performance Restricted Stock Unit 0 2025-02-05 4 M 0 152000 0 D Common Stock 152000 0 D Market-based Performance Restricted Stock Unit 0 Common Stock 181020 181020 D Market-based Performance Restricted Stock Unit 0 Common Stock 147260 147260 D Employee Stock Option (Right to Buy) 54.057 2029-03-01 Common Stock 151980 151980 D Employee Stock Option (Right to Buy) 59.881 2028-03-01 Common Stock 59970 59970 D Employee Stock Option (Right to Buy) 49.092 2030-03-01 Common Stock 181020 181020 D Employee Stock Option (Right to Buy) 30.033 2027-03-02 Common Stock 121400 121400 D Employee Stock Option (Right to Buy) 17.675 2026-03-01 Common Stock 113300 113300 D Employee Stock Option (Right to Buy) 98.153 2031-03-01 Common Stock 147240 147240 D On 03/01/2022, the Reporting Person received a target grant of 152,000 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025. The amount reported includes shares subject to unvested restricted stock units. The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025. The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026. The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027 The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025. The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024. The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026. The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027. Adjusted to reflect a ten-for-one forward split of the Issuer's common stock effective after market close on October 2, 2024. Marta Woods by Power of Attorney 2025-02-06